FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

773865008: Antidiabetic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726826013 Antidiabetic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726827016 Antidiabetic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antidiabetic therapeutic role (role) Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Medicinal product acting as antidiabetic agent (product) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing dapagliflozin and metformin and saxagliptin (medicinal product) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing only dapagliflozin and metformin and saxagliptin (medicinal product) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Dapagliflozin (as dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing dapagliflozin and metformin (medicinal product) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing dapagliflozin and metformin in oral dose form (medicinal product form) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing only dapagliflozin and metformin (medicinal product) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Dapagliflozin and metformin only product in oral dose form Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing only dapagliflozin and saxagliptin (medicinal product) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing dapagliflozin and saxagliptin in oral dose form (medicinal product form) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some
Dapagliflozin- and saxagliptin-containing product Plays role False Antidiabetic therapeutic role (role) Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start